Heart Failure Reviews最新文献_第8页

Disease features and management of cardiomyopathies in women. 女性心肌病的疾病特征和治疗方法。

IF 4.6 2区医学

Heart Failure Reviews Pub Date : 2024-05-01 Epub Date: 2024-02-03 DOI: 10.1007/s10741-024-10386-x

Alberto Aimo, Paolo Morfino, Chiara Arzilli, Giuseppe Vergaro, Valentina Spini, Iacopo Fabiani, Vincenzo Castiglione, Claudio Rapezzi, Michele Emdin

{"title":"Disease features and management of cardiomyopathies in women.","authors":"Alberto Aimo, Paolo Morfino, Chiara Arzilli, Giuseppe Vergaro, Valentina Spini, Iacopo Fabiani, Vincenzo Castiglione, Claudio Rapezzi, Michele Emdin","doi":"10.1007/s10741-024-10386-x","DOIUrl":"10.1007/s10741-024-10386-x","url":null,"abstract":"Over the last years, there has been a growing interest in the clinical manifestations and outcomes of cardiomyopathies in women. Peripartum cardiomyopathy is the only women-specific cardiomyopathy. In cardiomyopathies with X-linked transmission, women are not simply healthy carriers of the disorder, but can show a wide spectrum of clinical manifestations ranging from mild to severe manifestations because of heterogeneous patterns of X-chromosome inactivation. In mitochondrial disorders with a matrilinear transmission, cardiomyopathy is part of a systemic disorder affecting both men and women. Even some inherited cardiomyopathies with autosomal transmission display phenotypic and prognostic differences between men and women. Notably, female hormones seem to exert a protective role in hypertrophic cardiomyopathy (HCM) and variant transthyretin amyloidosis until the menopausal period. Women with cardiomyopathies holding high-risk features should be referred to a third-level center and evaluated on an individual basis. Cardiomyopathies can have a detrimental impact on pregnancy and childbirth because of the associated hemodynamic derangements. Genetic counselling and a tailored cardiological evaluation are essential to evaluate the likelihood of transmitting the disease to the children and the possibility of a prenatal or early post-natal diagnosis, as well as to estimate the risk associated with pregnancy and delivery, and the optimal management strategies.","PeriodicalId":12950,"journal":{"name":"Heart Failure Reviews","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11035404/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139671710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Advancing cardiac regeneration through 3D bioprinting: methods, applications, and future directions. 通过3D生物打印促进心脏再生：方法、应用和未来方向。

IF 4.6 2区医学

Heart Failure Reviews Pub Date : 2024-05-01 Epub Date: 2023-11-09 DOI: 10.1007/s10741-023-10367-6

Zilong Zheng, Weijie Tang, Yichen Li, Yinze Ai, Zhi Tu, Jinfu Yang, Chengming Fan

{"title":"Advancing cardiac regeneration through 3D bioprinting: methods, applications, and future directions.","authors":"Zilong Zheng, Weijie Tang, Yichen Li, Yinze Ai, Zhi Tu, Jinfu Yang, Chengming Fan","doi":"10.1007/s10741-023-10367-6","DOIUrl":"10.1007/s10741-023-10367-6","url":null,"abstract":"Cardiovascular diseases (CVDs) represent a paramount global mortality concern, and their prevalence is on a relentless ascent. Despite the effectiveness of contemporary medical interventions in mitigating CVD-related fatality rates and complications, their efficacy remains curtailed by an array of limitations. These include the suboptimal efficiency of direct cell injection and an inherent disequilibrium between the demand and availability of heart transplantations. Consequently, the imperative to formulate innovative strategies for cardiac regeneration therapy becomes unmistakable. Within this context, 3D bioprinting technology emerges as a vanguard contender, occupying a pivotal niche in the realm of tissue engineering and regenerative medicine. This state-of-the-art methodology holds the potential to fabricate intricate heart tissues endowed with multifaceted structures and functionalities, thereby engendering substantial promise. By harnessing the prowess of 3D bioprinting, it becomes plausible to synthesize functional cardiac architectures seamlessly enmeshed with the host tissue, affording a viable avenue for the restitution of infarcted domains and, by extension, mitigating the onerous yoke of CVDs. In this review, we encapsulate the myriad applications of 3D bioprinting technology in the domain of heart tissue regeneration. Furthermore, we usher in the latest advancements in printing methodologies and bioinks, culminating in an exploration of the extant challenges and the vista of possibilities inherent to a diverse array of approaches.","PeriodicalId":12950,"journal":{"name":"Heart Failure Reviews","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71521274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Development of a new miniaturized system for ultrafiltration. 开发新型微型超滤系统。

IF 4.6 2区医学

Heart Failure Reviews Pub Date : 2024-05-01 Epub Date: 2024-01-30 DOI: 10.1007/s10741-024-10384-z

Gonzalo Ramírez-Guerrero, Claudio Ronco, Anna Lorenzin, Alessandra Brendolan, Luca Sgarabotto, Monica Zanella, Thiago Reis

{"title":"Development of a new miniaturized system for ultrafiltration.","authors":"Gonzalo Ramírez-Guerrero, Claudio Ronco, Anna Lorenzin, Alessandra Brendolan, Luca Sgarabotto, Monica Zanella, Thiago Reis","doi":"10.1007/s10741-024-10384-z","DOIUrl":"10.1007/s10741-024-10384-z","url":null,"abstract":"Acute decompensated heart failure and fluid overload are the most common causes of hospitalization in heart failure patients, and often, they contribute to disease progression. Initial treatment encompasses intravenous diuretics although there might be a percentual of patients refractory to this pharmacological approach. New technologies have been developed to perform extracorporeal ultrafiltration in fluid overloaded patients. Current equipment allows to perform ultrafiltration in most hospital and acute care settings. Extracorporeal ultrafiltration is then prescribed and conducted by specialized teams, and fluid removal is planned to restore a status of hydration close to normal. Recent clinical trials and European and North American practice guidelines suggest that ultrafiltration is indicated for patients with refractory congestion not responding to medical therapy. Close interaction between nephrologists and cardiologists may be the key to a collaborative therapeutic effort in heart failure patients. Further studies are today suggesting that wearable technologies might become available soon to treat patients in ambulatory and de-hospitalized settings. These new technologies may help to cope with the increasing demand for the care of chronic heart failure patients. Herein, we provide a state-of-the-art review on extracorporeal ultrafiltration and describe the steps in the development of a new miniaturized system for ultrafiltration, called AD1 (Artificial Diuresis).","PeriodicalId":12950,"journal":{"name":"Heart Failure Reviews","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139575569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Assessment of patient-reported outcomes measures in heart failure: a systematic review 心力衰竭患者报告结果评估：系统性综述

IF 4.6 2区医学

Heart Failure Reviews Pub Date : 2024-04-17 DOI: 10.1007/s10741-024-10404-y

João Lázaro Mendes, Cristina Mendes dos Santos, Bernardo Sousa-Pinto

{"title":"Assessment of patient-reported outcomes measures in heart failure: a systematic review","authors":"João Lázaro Mendes, Cristina Mendes dos Santos, Bernardo Sousa-Pinto","doi":"10.1007/s10741-024-10404-y","DOIUrl":"https://doi.org/10.1007/s10741-024-10404-y","url":null,"abstract":"Heart failure (HF) is a prevalent global disease, particularly impacting developed countries. With the world’s aging population, HF’s impact on the quantity and quality of life is expected to grow. This review aims to ascertain the frequency, characteristics, and properties of all patient-reported outcomes measures (PROMs) studied in HF patients. We searched Ovid/Medline and Web of Science for original articles about PROMs performed in adults with HF. Using pre-established quality criteria for measurement properties, an overall rating was assigned to evaluate and compare different instruments. The quality of evidence was assessed with the COSMIN risk of bias checklist. Of 4283 records identified, we reviewed 296 full-text documents and included 64 papers, involving 30,185 participants. Thirty different PROMs were identified, with 14 specifically designed for HF being the most commonly used. Minnesota Living with Heart Failure (MLHF) and Kansas City Cardiomyopathy Questionnaire (KCCQ) were evaluated 16 and 13 times, respectively, demonstrating good psychometric properties. The MacNew Heart Disease Health-Related Quality of Life Questionnaire, a common heart disease-specific instrument, exhibited negative performances across various psychometric measures. Evidence for generic instruments was scant and unremarkable and they proved to be less responsive in HF populations. MLHF and KCCQ emerged as the most commonly used and well-supported PROMs, with robust overall evidence. They are comprehensive and accurate instruments, particularly suitable for application in clinical practice and research. Future research should explore how computer-adapted instruments can enhance precision, reduce respondent burden, and improve communication between clinicians and patients, thereby promoting more efficient and patient-centered services.","PeriodicalId":12950,"journal":{"name":"Heart Failure Reviews","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2024-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140614322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Correction to: Pediatric takotsubo cardiomyopathy: A review and insights from a National Multicentric Registry. 更正为小儿塔克次氏心肌病：来自全国多中心登记处的回顾与启示。

IF 4.6 2区医学

Heart Failure Reviews Pub Date : 2024-04-16 DOI: 10.1007/s10741-024-10401-1

Ravi Vazirani, Moisés Rodríguez-González, Ana Castellano-Martínez, Mireia Andrés, Aitor Uribarri, M. Corbí-Pascual, Fernando Alfonso, E. Blanco-Ponce, Carmen Lluch-Requerey, Clara Fernández-Cordón, Manuel Almendro-Delia, Oscar Vedia Cruz, Iván J Núñez-Gil

引用次数: 0

Resistance is not futile: a systematic review of the benefits, mechanisms and safety of resistance training in people with heart failure 阻力训练并非徒劳：对心力衰竭患者进行阻力训练的益处、机制和安全性的系统回顾

IF 4.6 2区医学

Heart Failure Reviews Pub Date : 2024-04-15 DOI: 10.1007/s10741-024-10402-0

Bradley A. Morris, Ronak Sinaei, Neil A. Smart

{"title":"Resistance is not futile: a systematic review of the benefits, mechanisms and safety of resistance training in people with heart failure","authors":"Bradley A. Morris, Ronak Sinaei, Neil A. Smart","doi":"10.1007/s10741-024-10402-0","DOIUrl":"https://doi.org/10.1007/s10741-024-10402-0","url":null,"abstract":"Exercise offers many physical and health benefits to people with heart failure (CHF), but aerobic training (AT) predominates published literature. Resistance training (RT) provides additional and complementary health benefits to AT in people with CHF; we aimed to elucidate specific health benefits accrued, the mechanism of effect and safety of RT. We conducted a systematic search for RT randomised, controlled trials in people with CHF, up until August 30, 2023. RT offers several benefits including improved physical function (peak VO2 and 6MWD), quality of life, cardiac systolic and diastolic function, endothelial blood vessel function, muscle strength, anti-inflammatory muscle markers, appetite and serious event rates. RT is beneficial and improves peak VO2 and 6MWD, partly restores normal muscle fibre profile and decreases inflammation. In turn this leads to a reduced risk or impact of sarcopenia/cachexia via effect on appetite. The positive impact on quality of life and performance of activities of daily living is related to improved function, which in turn improves prognosis. RT appears to be safe with only one serious event reported and no deaths. Nevertheless, few events reported to date limit robust analysis. RT appears to be safe and offers health benefits to people with CHF. RT modifies the adverse muscle phenotype profile present in people with CHF and it appears safe. Starting slowly with RT and increasing load to 80% of 1 repetition maximum (RM) appears to offer optimal benefit.","PeriodicalId":12950,"journal":{"name":"Heart Failure Reviews","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140593958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Comparative analysis of treatment options for chronic heart failure and depression: a systematic review and Bayesian network meta-analysis 慢性心力衰竭和抑郁症治疗方案的比较分析：系统综述和贝叶斯网络荟萃分析

IF 4.6 2区医学

Heart Failure Reviews Pub Date : 2024-04-13 DOI: 10.1007/s10741-024-10403-z

Hamidreza Soleimani, Ali Nasrollahizadeh, Mohsen Hajiqasemi, Mandana Ebrahimzade, Homa Taheri, Pouya Ebrahimi, Haleh Ashraf, Marc D. Samsky, Kaveh Hosseini

{"title":"Comparative analysis of treatment options for chronic heart failure and depression: a systematic review and Bayesian network meta-analysis","authors":"Hamidreza Soleimani, Ali Nasrollahizadeh, Mohsen Hajiqasemi, Mandana Ebrahimzade, Homa Taheri, Pouya Ebrahimi, Haleh Ashraf, Marc D. Samsky, Kaveh Hosseini","doi":"10.1007/s10741-024-10403-z","DOIUrl":"https://doi.org/10.1007/s10741-024-10403-z","url":null,"abstract":"Different interventions have been evaluated for the treatment of depression in heart failure (HF) patients. However, clear and established recommendations are lacking. PubMed, Scopus, and Web of Science databases were systematically searched for randomized controlled trials (RCT) evaluating the effect of various treatment options on depression scores in heart failure patients. The primary outcome was a change in depression scores presented as standardized mean difference (SMD). A Bayesian network for meta-analysis was constructed. Twenty-five RCTs were included, randomizing 6014 patients with confirmed heart failure and depression between 2003 and 2022. Compared to treatment as usual (TAU), only cognitive behavioral therapy (CBT) (SMD − 0.60, CI95% [− 1.0, − 0.17]) leads to a significant reduction in depression scores. Other interventions did not improve depression scores significantly. Our results show that for patients with HF and depression, CBT can significantly improve measures of depression, being the most efficacious treatment.","PeriodicalId":12950,"journal":{"name":"Heart Failure Reviews","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2024-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140593842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Abnormal phosphorylation / dephosphorylation and Ca2+ dysfunction in heart failure 心力衰竭的异常磷酸化/去磷酸化和 Ca2+ 功能障碍

IF 4.6 2区医学

Heart Failure Reviews Pub Date : 2024-03-18 DOI: 10.1007/s10741-024-10395-w

Yan-Bing Liu, Qian Wang, Yu-Ling Song, Xiao-Min Song, Yu-Chen Fan, Lin Kong, Jing-Sai Zhang, Sheng Li, Yi-Ju Lv, Ze-Yang Li, Jing-Yu Dai, Zhen-Kang Qiu

{"title":"Abnormal phosphorylation / dephosphorylation and Ca2+ dysfunction in heart failure","authors":"Yan-Bing Liu, Qian Wang, Yu-Ling Song, Xiao-Min Song, Yu-Chen Fan, Lin Kong, Jing-Sai Zhang, Sheng Li, Yi-Ju Lv, Ze-Yang Li, Jing-Yu Dai, Zhen-Kang Qiu","doi":"10.1007/s10741-024-10395-w","DOIUrl":"https://doi.org/10.1007/s10741-024-10395-w","url":null,"abstract":"Heart failure (HF) can be caused by a variety of causes characterized by abnormal myocardial systole and diastole. Ca2+ current through the L-type calcium channel (LTCC) on the membrane is the initial trigger signal for a cardiac cycle. Declined systole and diastole in HF are associated with dysfunction of myocardial Ca2+ function. This disorder can be correlated with unbalanced levels of phosphorylation / dephosphorylation of LTCC, endoplasmic reticulum (ER), and myofilament. Kinase and phosphatase activity changes along with HF progress, resulting in phased changes in the degree of phosphorylation / dephosphorylation. It is important to realize the phosphorylation / dephosphorylation differences between a normal and a failing heart. This review focuses on phosphorylation / dephosphorylation changes in the progression of HF and summarizes the effects of phosphorylation / dephosphorylation of LTCC, ER function, and myofilament function in normal conditions and HF based on previous experiments and clinical research. Also, we summarize current therapeutic methods based on abnormal phosphorylation / dephosphorylation and clarify potential therapeutic directions.","PeriodicalId":12950,"journal":{"name":"Heart Failure Reviews","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2024-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140149885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Incremental diagnostic and prognostic utility of left atrial deformation in heart failure using speckle tracking echocardiography 利用斑点追踪超声心动图对心力衰竭患者的左心房变形进行增量诊断和预后评估

IF 4.6 2区医学

Heart Failure Reviews Pub Date : 2024-03-11 DOI: 10.1007/s10741-024-10392-z

Ashraf M. Anwar

{"title":"Incremental diagnostic and prognostic utility of left atrial deformation in heart failure using speckle tracking echocardiography","authors":"Ashraf M. Anwar","doi":"10.1007/s10741-024-10392-z","DOIUrl":"https://doi.org/10.1007/s10741-024-10392-z","url":null,"abstract":"Left atrium (LA) is a very important component of cardiovascular performance. The assessment of LA function has gathered the interest with expanding research supporting the utility as a biomarker for outcomes in heart failure (HF). Echocardiography is the main imaging modality which helps in a qualitative and quantitative assessment of the LA size and function. Recent advances in probe technology and software analysis have provided a better understanding of LA anatomy, physiology, pathology, and function. A variety of parameters have been defined as markers of LA function but there is no single parameter that best defines LA function. Speckle tracking echocardiography–derived analysis of LA deformation provides a window on all phases of LA function (reservoir, conduit, and booster pump). There is accumulative published data that supported the diagnostic and prognostic values of LA deformation integration during echo assessment of LA in HF. This review article summarized the clinical utility of LA deformation that may help in prediction, diagnosis, categorization, risk stratification, and guiding the proper selection of therapy in HF patients in daily practice.","PeriodicalId":12950,"journal":{"name":"Heart Failure Reviews","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2024-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140099165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Correction to: Clinical staging of Anderson‑Fabry cardiomyopathy: an operative proposal. 更正：安德森-法布里心肌病的临床分期：一项手术建议。

IF 4.6 2区医学

Heart Failure Reviews Pub Date : 2024-03-01 DOI: 10.1007/s10741-023-10379-2

Annamaria Del Franco, Giulia Iannaccone, Maria Chiara Meucci, Rosa Lillo, Francesco Cappelli, Chiara Zocchi, Maurizio Pieroni, Francesca Graziani, Iacopo Olivotto

引用次数: 0